India’s new TB vaccine for adolescents, adults set for launch

Sumit Jha Nov 25, 2025 Health

[{"selector":"#anim-eac4603a-23fc-4abf-90f2-141e3672051b [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(31.249999886225726%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] Health A new tuberculosis (TB) vaccine for adolescents and adults, the HSP Subunit Vaccine in Adjuvant (DDA), is now ready for commercialisation. Read the article

[{"selector":"#anim-7e6aa31a-dd73-4192-bce1-33aa4dd690aa [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Health Existing vaccines offer limited protection, mainly for infants, and are largely ineffective in preventing pulmonary TB in older age groups. The new vaccine aims to fill this critical gap. Read the article

[{"selector":"#anim-010dadb8-6a1f-480e-baa2-ecc52013e918 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Health The vaccine was developed through collaborative research by IIT Bhubaneswar and the Institute of Life Sciences (ILS), Bhubaneswar, under the Department of Biotechnology. Read the article

[{"selector":"#anim-ce0cb344-7365-489a-8507-f5f2003b6474 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-7.812499744007886%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] Health The NRDC facilitated the technology transfer and evaluation process, ensuring that the innovation moves efficiently from research to product development. Read the article

[{"selector":"#anim-d620427c-445b-4493-b341-909d7804d7be [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-12.495507678509487%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] Health To advance the commercialisation of the vaccine, a quadripartite license agreement (QLA) has been signed with TechInvention Lifecare Limited. Read the article